Order Sucraid®
Important Safety Information
Prescribing Information
Patient Site

Sucraid® assistance patient support program

The Sucraid® assistance patient support program is provided by the specialty pharmacy and offers support services to patients with Congenital Sucrase-Isomaltase Deficiency (CSID), their caregivers, and their healthcare providers. Contact the specialty pharmacy at 1-800-705-1962 for more information.

Try Sucraid®
4-Day Trial

See if Sucraid® is right for your patients diagnosed 
with CSID.

Try Sucraid®

Sucraid® assistance patient support program

Help with problems getting Sucraid® prescription filled

  • Copay assistance may be available
  • Deductible and premium support
Financial Assistance Information
  • Prior authorization assistance
  • Most plans cover Sucraid®
  • Assistance with an appeal of Medicaid and Medicare plans if coverage for Sucraid® is initially denied
  • Resources for diet management
Nutritional Support

To enroll in the financial assistance program

Electronic Enrollment

Click the link below to complete the form.

Online Enrollment Form

Our specialty
pharmacy

Learn how to order Sucraid®
from our specialty pharmacy.

How to Order
Important Safety Information
Sucraid® (sacrosidase) Oral Solution
  • Do not prescribe Sucraid® to patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.
Indication
Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.